论文部分内容阅读
目的:观察血栓通联合倍他司汀治疗椎-基底动脉缺血性眩晕疗效。方法:治疗组35例予倍他司汀联合血栓通静脉滴注,对照组30例予丹参联合脉络宁静脉滴注。全部病例治疗前后均作经颅多普勒(TCD)检查。结果:按痊愈、好转、无效划分,治疗组分别为29、4、2例,总有效率为95%;对照组分别为18、4、8例,总有效率为73%(P<0.01)。结论:血栓通联合倍他司汀治疗椎-基底动脉缺血性眩晕的效果优于丹参联合脉络宁的治疗效果。
Objective: To observe the therapeutic effect of Xueshuantong combined with Betatine on vertebrobasilar ischemic vertigo. Methods: 35 cases in the treatment group were given Betacetin combined with Xueshuantong intravenously, and 30 cases in the control group were given Danshen combined with Mailuoning intravenously. All cases were treated by transcranial Doppler (TCD) before and after treatment. The total effective rate was 95%; the control group was 18, 4 and 8 cases respectively, the total effective rate was 73% (P <0.01) . Conclusion: The effect of Xueshuantong combined with Betatine in treating vertebrobasilar ischemic vertigo is better than that of Salvia Miltiorrhiza combined with Mailuoning.